Pharmaceutical drug delivery market was valued at $1,200ย billion in 2018, and is expected to reach $1,733ย billion by 2026, registering a CAGR of 4.7% from 2019 to 2026.

Pharmaceutical drug delivery (DDS) systems are defined as drug formulations, which are responsible for controlling the administration of medications with the aid of a chemical or a physiological trigger, thereby delivering medications to specially targeted parts of a patientโ€™s body. Moreover, these systems are used to enhance drug absorption, efficacy, and patient experience. In addition, DDSs provide protection against the biochemical degradation of pharmaceutical agents.

List of Key Players

The global pharmaceutical drug delivery market is highly competitive, owing to presence of prominent players in the market. These players have adopted various strategies to garner maximum market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market are Bayer AG, Becton, Dickinson And Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, 3M Company, Pfizer Inc., and Sanofi.

Download Sample Report:

The global pharmaceutical drug delivery market size is studied on the basis of route of administration, application, and region to provide a detailed assessment of the market. Depending on route of administration, the market is segmented into oral drug delivery system, pulmonary drug delivery, ocular drug delivery systems, nasal drug delivery system, ocular drug delivery, topical drug delivery, and others. The applications covered in the study include cancer, diabetes, respiratory diseases, cardiovascular diseases, and others. Region wise, the pharmaceutical drug delivery market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, and rest of LAMEA).

According to route of administration, the others segment occupied the largest share of pharmaceutical drug delivery market in 2018, and is expected to grow at the fastest pace during the forecast period, owing to rise in awareness related to the use of drug delivery systems and increase in healthcare expenditure.

By application, the cancer segment occupied the largest share of the pharmaceutical drug delivery market, in 2018. This growth is attributable to surge in prevalence of cancer. Moreover, rise in need for novel and advanced therapeutics required for cancer treatment is acts as a key factor that boosts the growth of the global market. However, the others segment is expected to grow at the fastest pace during the forecast period, owing to alarming increase in prevalence of various disorders such as respiratory disorders such as asthma and bronchitis.  

For Purchase inquiry:

๐€๐›๐จ๐ฎ๐ญ ๐€๐ฅ๐ฅ๐ข๐ž๐ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of the domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Leave a comment

Your email address will not be published. Required fields are marked *